By Natalie Rahhal Deputy Health Editor For Dailymil.com
Published: 23:25 BST, 4 April 2019 | Updated: 23:25 BST, 4 April 2019
The US Food and Drug Administration is urging patients to keep taking contaminated blood pressure medication amid shortages of the drugs.
In July, the FDA began recalling some valsartan blood pressure drugs after discovering they had a chemical impurity that may race cancer risks.
As the list of contaminated versions of the drugs grew, an alarming number of Americans were left without access to the life-saving medications.
Now, the FDA has walked back its warnings, advising Americans to keep taking minimally-contaminated blood pressure drugs until manufacturers have had a chance to replenish this supply with impurity free ones.
Many valsartan-containing blood pressure drugs were recalled for being tainted with a possible carcinogen, leading to a shortage. On Thursday, the FDA said taking the contaminated drugs is safer than taking none
An estimated one in three Americans may need to take blood pressure medications.
But since July, a slew of drugs containing valsartan,